The delegation, which included senior government and party officials as well as business leaders, engaged in talks with Richter’s top executives. Representing Richter were CEO Gabor Orban, Chairman of the Board of Directors Prof. Dr. E. Szilveszter Vizi, Commercial Director Tamas Szolyak, and CFO Laszlo Andras Kovacs.

During the meeting, the Chinese side emphasized its strong interest in high-quality, affordable medicines to meet the needs of an increasingly health-conscious population. They also expressed openness to bilateral partnerships, particularly those involving companies like Richter that are recognized for their contributions to pharmaceutical innovation and scientific research.

CEO Gabor Orban welcomed the prospect of deeper cooperation, underscoring the value of equal partnerships where both parties invest in research and development. He highlighted the importance of high-level exchanges like this one, noting their role in building trust and enhancing mutual understanding.

Both parties agreed to maintain ongoing communication and explore further opportunities for collaboration between Richter and Guangdong Province, aiming to build on the momentum generated by this visit.